What is Arcadia?
Founded in 2002 and headquartered outside Boston in Burlington, MA, Arcadia is a recognized leader in healthcare data analytics and technology. With offices across the United States, the company has been lauded by industry analysts such as Chilmark, Gartner, and KLAS for its innovative solutions. Arcadia's platform is designed to aggregate and harmonize disparate health data, enabling providers, payers, and life sciences organizations to improve patient outcomes, optimize operations, and drive value-based care initiatives. The company's extensive experience in managing complex healthcare datasets positions it as a critical player in the ongoing digital transformation of the healthcare industry.
How much funding has Arcadia raised?
Arcadia has raised a total of $168M across 3 funding rounds:
Private Equity
$13M
Private Equity
$30M
Other Financing Round
$125M
Private Equity (2015): $13M with participation from Peloton Equity and Zaffre Investments
Private Equity (2017): $30M led by Peloton Equity, GE Ventures, Zaffre Investments, and Morgan Stanley Alternative Investment Partners
Other Financing Round (2023): $125M supported by Vista Equity Partners
Key Investors in Arcadia
Vista Equity Partners
Vista Equity Partners is a leading global investment firm focused exclusively on enterprise software, data, and technology-enabled organizations. They employ a disciplined approach to investing and aim to create enduring market value through their expertise in structuring technology-oriented transactions and management techniques.
Peloton Equity
Peloton Equity is a growth capital investor specializing in the healthcare sector. They partner with lower-middle-market healthcare companies, leveraging their extensive network and experience to support growth objectives and optimize business models.
Zaffre Investments
Zaffre Investments, LLC, a subsidiary of Blue Cross Blue Shield of Massachusetts, invests in new products, services, and technologies to improve healthcare delivery. They focus on companies across the healthcare landscape, including ACOs, consumer solutions, and health information technology.
What's next for Arcadia?
The recent major strategic investment in Arcadia signals a pivotal phase for the company, likely aimed at accelerating product development, expanding market reach, and enhancing its data integration capabilities. Given the enterprise-level context of its total funding, Arcadia appears poised for significant scaling, potentially through strategic acquisitions or deeper penetration into new healthcare verticals. This capital infusion will be crucial for Arcadia to maintain its competitive edge, further innovate its technology stack, and solidify its role as a key enabler of data-driven healthcare.
See full Arcadia company page
